Company Overview of Endocube
As of December 3, 2008, Endocube went out of business. Endocube uses cellular genomics technology to research on endothelium cell biology and the inflammation cascade. It researches to cure diseases, such as asthma, diabetes, and rheumatoid arthritis. The company was founded in 2001 and is based in Labège, France.
Rue Pierre et Marie Curie
Founded in 2001
Key Executives for Endocube
Endocube does not have any Key Executives recorded.
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Endocube, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.